SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-25-003026 to Moolec Science SA (MLEC)

Moolec Science SA
Date: March 20, 2025 · CIK: 0001937737 · Accession: 0000000000-25-003026

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-284744

Date
March 20, 2025
Author
Finance
Form
UPLOAD
Company
Moolec Science SA

Letter

Re: Moolec Science SA Amendment No. 1 to Registration Statement on Form F-4 Filed March 10, 2025 File No. 333-284744 Dear Jose Lopez Lecube:

March 20, 2025

Jose Lopez Lecube Chief Financial Officer Moolec Science SA 17, Boulevard F.W. Raiffeisen L-2411 Luxembourg Grand Duchy of Luxembourg

We have conducted a limited review of your amended registration statement and have the following comments.

Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response.

After reviewing any amendment to your registration statement and the information you provide in response to this letter, we may have additional comments. Unless we note otherwise, any references to prior comments are to comments in our February 26, 2025 letter.

Amendment No. 1 to Registration Statement on Form F-4 filed March 10, 2025 Exhibits

1. We note your response to prior comment 3. Please file as Exhibit 8.1 a revised opinion that states clearly that the disclosure in the Prospectus under the heading Luxembourg Tax Considerations is the opinion of counsel and includes counsel's consent. Refer to Section III.B.2. of Staff Legal Bulletin 19. 2. We note your response to prior comment 4. Please file as Exhibit 8.3 a revised opinion that states clearly that the disclosure in the Prospectus under the heading Cayman Islands Tax Considerations" is the opinion of counsel and includes counsel's consent to the filing of this exhibit and to the reference to its name in each location. Refer to Section III.B.2. of Staff Legal Bulletin 19. March 20, 2025 Page 2

Please contact Thomas Jones at 202-551-3602 or Geoffrey Kruczek at 202-551-3641 with any questions.

Sincerely,
Division of Corporation
Finance
Office of Manufacturing
cc: Matthew Poulter

Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 March 20, 2025

Jose Lopez Lecube
Chief Financial Officer
Moolec Science SA
17, Boulevard F.W. Raiffeisen
L-2411 Luxembourg
Grand Duchy of Luxembourg

 Re: Moolec Science SA
 Amendment No. 1 to Registration Statement on Form F-4
 Filed March 10, 2025
 File No. 333-284744
Dear Jose Lopez Lecube:

 We have conducted a limited review of your amended registration
statement and have
the following comments.

 Please respond to this letter by amending your registration statement
and providing
the requested information. If you do not believe a comment applies to your
facts and
circumstances or do not believe an amendment is appropriate, please tell us why
in your
response.

 After reviewing any amendment to your registration statement and the
information
you provide in response to this letter, we may have additional comments. Unless
we note
otherwise, any references to prior comments are to comments in our February 26,
2025 letter.

Amendment No. 1 to Registration Statement on Form F-4 filed March 10, 2025
Exhibits

1. We note your response to prior comment 3. Please file as Exhibit 8.1 a
revised
 opinion that states clearly that the disclosure in the Prospectus under
the heading
 Luxembourg Tax Considerations is the opinion of counsel and
includes counsel's
 consent. Refer to Section III.B.2. of Staff Legal Bulletin 19.
2. We note your response to prior comment 4. Please file as Exhibit 8.3 a
revised
 opinion that states clearly that the disclosure in the Prospectus under
the heading
 Cayman Islands Tax Considerations" is the opinion of counsel and
includes counsel's
 consent to the filing of this exhibit and to the reference to its name
in each
 location. Refer to Section III.B.2. of Staff Legal Bulletin 19.
 March 20, 2025
Page 2

 Please contact Thomas Jones at 202-551-3602 or Geoffrey Kruczek at
202-551-3641
with any questions.

 Sincerely,

 Division of Corporation
Finance
 Office of Manufacturing
cc: Matthew Poulter
</TEXT>
</DOCUMENT>